SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-007832
Filing Date
2022-01-26
Accepted
2022-01-26 16:15:47
Documents
14
Period of Report
2022-01-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm224508d1_8k.htm   iXBRL 8-K 34742
2 EXHIBIT 10.2 tm224508d1_ex10-2.htm EX-10.2 42003
  Complete submission text file 0001104659-22-007832.txt   318905

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA eucr-20220120.xsd EX-101.SCH 3857
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eucr-20220120_def.xml EX-101.DEF 27680
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE eucr-20220120_lab.xml EX-101.LAB 38697
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eucr-20220120_pre.xml EX-101.PRE 26298
8 EXTRACTED XBRL INSTANCE DOCUMENT tm224508d1_8k_htm.xml XML 6690
Mailing Address 250 WEST 55TH STREET, SUITE 13D NEW YORK NY 10019
Business Address 250 WEST 55TH STREET, SUITE 13D NEW YORK NY 10019 (212) 710-5220
Eucrates Biomedical Acquisition Corp. (Filer) CIK: 0001822929 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8
Type: 8-K | Act: 34 | File No.: 001-39650 | Film No.: 22558076
SIC: 6770 Blank Checks